Medication non‐adherence is currently estimated to have caused at least 100 000
preventable deaths and over $100 billion in preventable medical costs. Adherence is …

Purpose Clinical pharmacy can reduce drug-related iatrogenesis by improving the
management of adverse effects of drugs, limiting drug–drug interactions, and improving …

Background Hospital admission and discharge are at high risk of drug‐related problems
(DRPs) in older patients with cancer. This study aimed to assess the clinical and economic …

The Oncology Pharmacy Team (OPT), consisting of specialty-trained pharmacists and/or
pharmacy technicians, is an integral component of the multidisciplinary healthcare team …

Background: More than 50% of patients with lung cancer are admitted to the hospital while
receiving treatment, which is a burden to patients and the healthcare system. This study …

Abstract Background In France, hospital pharmacists perform medication order reviews
during patients' hospital stays. This activity can be centralized in the pharmacy or carried out …

Background The economic benefit of the clinical pharmacist's role in ensuring the optimum
use of medicines is potentially considerable, particularly when it comes to cancer …

Introduction Children with cancer may be one of the most vulnerable groups to drug-related
adverse events because they possess characteristics of patients with cancer as well as …

Background Clinical pharmacy is a discipline structured around multiple activities whose
objective is to secure patient care. Among all the specialties where it can be applied …

We sought to investigate the economic impact of preventing adverse events in a cardiology
setting in Qatar as an effect of the clinical pharmacist as an intervention. This is a …